Achieve Life Sciences Inc. (ACHV)
Symbol Info
Listed Symbol ACHV
Name Achieve Life Sciences Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $-
Latest Fiscal EPS $-4.87
Price Info
21 Day Moving Average $1.8948
21 Day EMA $1.799270
50 Day Moving Average $1.9356
50 Day EMA $1.963660
200 Day EMA $2.811130
200 Day Moving Average 2.444800
52 Week High $4.63
52 Week Low $1.04
52 Week Change $-31.601700
Alpha -0.062576
Beta 1.9515
Standard Deviation 0.240202
R2 0.077927
Periods 60
Share Information
10 Day Average Volume 111,787
20 Day Average Volume 113,824
30 Day Average Volume 136,759
50 Day Average Volume 119,342
Outstanding Shares 8,097,763
Float Shares 7,243,350
Percent Float 89.45%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 33
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 364,148
Institute Holdings Percent 21.100000
Institute Sold Previous 3 Months 54,262
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 2
Insider Holdings Percent 10.60%
Insider Sold Previous 3 Months -
Insiders Shares Owned 854,413
Price Change
7 Day Price Change $-0.01
7 Day Percent Change -0.63%
21 Day Price Change $-0.66
21 Day Percent Change -29.46%
30 Day Price Change $-0.7195
30 Day Percent Change -31.29%
Month To Date Price Change $-0.12
Month To Date Percent -7.06%
90 Day Price Change $-0.19
90 Day Percent Change -10.73%
Quarter To Date $-0.12
Quarter To Date Percent -7.06%
180 Day Price Change $-1.97
180 Day Percent Change -55.49%
200 Day Price Change $-1.44
200 Day Percent Change -47.68%
Year To Date $0.370000
Year To Date Percent 30.58%
Profile
Description Achieve Life Sciences Inc is a United States based clinical-stage biopharmaceutical company. It is focused on the development of novel next-generation cancer therapeutics. The company's product candidate is apatorsen which is designed to block the production of heat shock protein 27, or Hsp27, a protein that promotes treatment resistance in cancer. The group has business offices located in Bothell, Washington and Vancouver, British Columbia.
Details
Issue Type CS
Market Cap $12,794,466
Sec Type EQS
Auditor PricewaterhouseCoopers LLP
Total Shares Outstanding 8,097,763
CEO Richard Alistair Balfour Stewart
Employees 13
Last Audit UE
Classification
CIK 0000949858
Industry Biotechnology
Sector Healthcare
NAICS In-Vitro Diagnostic Substance Manufacturing(325413)
Info
Address 1040 West Georgia Street
Suite 1030
Bothell, WA V6E 4H1
Website http://www.achievelifesciences.com
Facisimile
Telephone +1 604) 210-2217
Email sspecht@oncogenex.com
Key Ratios
Profitability
EBIT Margin -
EBITDA Margin -
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $-
Revenue Per Share $-
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $3,775,197
Price To Sales -
Price To Free Cash -1
PE High Last 5 Years -
Price To Book 1.1
Price To Cash Flow 4.8
PE Low Last 5 Years -
Price To Tangible Book 1.5
Financial Strength
Total Debt To Equity 0.0
Int Coverage -
Current Ratio 3.6
Leverage Ratio 1.3
Quick Ratio 3.5
Long Term Debt To Capital 0.02
Assets
Receivables Turnover -
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -96.57
Return On Equity -117.4
Return On Capital -117.14
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
ACHV
Achieve Li..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.